Bourgeon Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.1M Buy
163,890
+923
+0.6% +$108K 3.1% 6
2026
Q1
$19.6M Sell
162,967
-1,389
-0.8% -$160K 3.39% 4
2025
Q4
$17.3M Sell
164,356
-2,871
-2% -$270K 2.8% 9
2025
Q3
$14M Buy
167,227
+6,321
+4% +$521K 2.53% 13
2025
Q2
$12.7M Buy
160,906
+10,748
+7% +$854K 2.51% 12
2025
Q1
$13.5M Buy
150,158
+2,321
+2% +$217K 2.9% 4
2024
Q4
$14.7M Buy
147,837
+1,031
+0.7% +$106K 2.75% 6
2024
Q3
$16.7M Buy
146,806
+3,316
+2% +$394K 3.21% 5
2024
Q2
$17.8M Sell
143,490
-66
-0% -$8.5K 3.48% 4
2024
Q1
$18.9M Buy
143,556
+1,137
+0.8% +$140K 3.71% 3
2023
Q4
$15.5M Sell
142,419
-592
-0.4% -$61.5K 3.43% 6
2023
Q3
$14.7M Buy
143,011
+91
+0.1% +$9.81K 3.46% 4
2023
Q2
$16.5M Sell
142,920
-245
-0.2% -$27.8K 3.85% 3
2023
Q1
$15.2M Buy
143,165
+44
+0% +$4.75K 3.63% 3
2022
Q4
$15.9M Sell
143,121
-25,893
-15% -$2.65M 3.9% 3
2022
Q3
$14.6M Buy
169,014
+1,140
+0.7% +$102K 4% 1
2022
Q2
$15.3M Buy
167,874
+1,170
+0.7% +$104K 4.05% 1
2022
Q1
$13.7M Sell
166,704
-506
-0.3% -$39.9K 3.09% 7
2021
Q4
$12.8M Sell
167,210
-942
-0.6% -$75K 2.64% 13
2021
Q3
$12.6M Buy
168,152
+3,065
+2% +$233K 2.7% 12
2021
Q2
$12.8M Buy
165,087
+4,474
+3% +$333K 2.76% 8
2021
Q1
$11.8M Buy
160,613
+9,474
+6% +$699K 2.62% 10
2020
Q4
$11.8M Buy
151,139
+35,348
+31% +$2.7M 2.91% 7
2020
Q3
$9.16M Buy
115,791
+807
+0.7% +$63.2K 2.78% 10
2020
Q2
$8.48M Buy
114,984
+23,600
+26% +$1.78M 3.02% 9
2020
Q1
$6.71M Buy
91,384
+13,789
+18% +$1.08M 3.48% 8
2019
Q4
$6.73M Sell
77,595
-27,798
-26% -$2.28M 3.18% 9
2019
Q3
$8.47M Buy
105,393
+7,718
+8% +$619K 4.59% 1
2019
Q2
$7.82M Sell
97,675
-456
-0.5% -$34.9K 4.53% 3
2019
Q1
$7.79M Sell
98,131
-2,133
-2% -$160K 4.57% 1
2018
Q4
$7.31M Sell
100,264
-11,055
-10% -$780K 4.78% 1
2018
Q3
$7.54M Sell
111,319
-20,457
-16% -$1.3M 3.89% 3
2018
Q2
$7.63M Sell
131,776
-1,414
-1% -$79.8K 4.1% 3
2018
Q1
$6.92M Buy
133,190
+2,436
+2% +$132K 3.78% 3
2017
Q4
$7.02M Buy
130,754
+34,034
+35% +$1.89M 3.84% 2
2017
Q3
$5.91M Buy
96,720
+681
+0.7% +$41.3K 3.48% 5
2017
Q2
$5.87M Sell
96,039
-602
-0.6% -$36.6K 3.68% 5
2017
Q1
$5.86M Buy
96,641
+4,543
+5% +$276K 3.66% 3
2016
Q4
$5.17M Buy
92,098
+6,943
+8% +$406K 3.25% 4
2016
Q3
$5.07M Sell
85,155
-6,283
-7% -$367K 3.25% 5
2016
Q2
$5.03M Sell
91,438
-1,258
-1% -$67K 3.26% 4
2016
Q1
$4.68M Sell
92,696
-2,305
-2% -$113K 3.13% 5
2015
Q4
$4.79M Buy
95,001
+1,257
+1% +$63.4K 3.07% 6
2015
Q3
$4.42M Buy
93,744
+39,405
+73% +$2.09M 3.08% 4
2015
Q2
$2.95M Buy
54,339
+2,620
+5% +$147K 1.79% 25
2015
Q1
$2.84M Sell
51,719
-1,153
-2% -$65.3K 1.74% 25
2014
Q4
$2.87M Sell
52,872
-209
-0.4% -$11.6K 1.75% 25
2014
Q3
$3M Hold
53,081
1.75% 23
2014
Q2
$2.93M Buy
53,081
+7,021
+15% +$383K 1.6% 29
2014
Q1
$2.5M Sell
46,060
-31,178
-40% -$1.61M 1.57% 28
2013
Q4
$3.69M Buy
77,238
+1,625
+2% +$74.3K 2.37% 13
2013
Q3
$3.44M Sell
75,613
-3,773
-5% -$172K 2.32% 12
2013
Q2
$3.52M Buy
+79,386
New +$3.55M 2.51% 5

Other funds holding MRK

Bourgeon Capital Management's MRK Position: Q2 2026 in Review

Bourgeon Capital Management increased its Merck (MRK) stake by 0.57% in Q2 2026, buying an estimated $108K and bringing the position to 163,890 shares worth $21.1M. The position accounts for 3.1% of the portfolio, ranked #6.

Bourgeon Capital Management first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. 1,766 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Bourgeon Capital Management held 163,890 shares of Merck worth $21.1M as of Q2 2026.
  • Bourgeon Capital Management bought 923 Merck shares in Q2 2026, an estimated $108K.
  • Merck made up 3.1% of Bourgeon Capital Management's portfolio in Q2 2026, its #6 holding.
  • Bourgeon Capital Management first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • 1,766 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Bourgeon Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.